POSTER SESSION III
Tuesday, March 10, 2009 — 9:30 AM - 12:00 Noon
Hynes CC Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
LIVER & PANCREAS PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
149
Histopathology of De Novo Autoimmune Hepatitis in Children
(1431)
A Manuyakorn, RS Venick, SV McDiarmid, CR Lassman - Siriraj Hospital, Bangkok, Thailand; UCLA, Los Angeles, CA
Cirrhosis in Young Chronic Hepatitis B Patients with Low Viral Load and HBeAg-Negative Status: Result of Extended Screening for Co-Morbidities
(1459)
K Sivarajah, OA Adeyi - University of Toronto/UHN, Toronto, ON, Canada
Fibro-Inflammatory, Ductulo-Obliterative Lesions in Hepatitis C Cirrhosis
(1477)
WM Yu, JS Lambe, A Gupta, JH Lefkowitch - Columbia Presbyterian Medical Center, New York, NY
Increased Expression of Inhibitory B7 Family Members Associated with Chronic Hepatitic Necroinflammatory Disease
(1401)
MW Cruise, R Kassel, TL Pruett, YS Hahn, JC Iezzoni - University of Virginia, Charlottesville; University of Virgina, Charlottesville, VA
The Role of Hepatic Progenitor Cell Activation and Periportal Ductular Reaction Presence in Chronic Hepatitis C and B. A Clinicopathologic Study
(1468)
A Tsamandas, K Thomopoulos, I Syrokosta, D Dimitropoulou, C Karatza, C Gogos - University of Patras, Patras, Greece
The Role of Oval Cell Activation and Oxidative Stress in Two Different Models of Experimental Cirrhosis
(1413)
C Kalogeropoulou, I Tsota, P Zabakis, T Petsas, D Kardamakis, A Tsamandas - University of Patras School of Medicine, Patras, Greece
The Severity of Histological Lesions Is Predictive of Outcome in 138 Patients with Alcoholic Steatohepatitis
(1460)
L Spahr, E Giostra, A Hadengue, L Rubbia-Brandt - University Hospitals of Geneva, Geneva, Switzerland
Acidophil Body Index May Help Diagnosing Non-Alcoholic Steatohepatitis
(1476)
MM Yeh, P Belt, EM Brunt, KV Kowdley, A Unalp, L Wilson, L Ferrell - University of Washington, Seattle, WA; Johns Hopkins University, Baltimore, MD; Washington University, St. Louis, MO; Virginia Mason Medical Center, Seattle, WA; University of California, San Francisco, San Francisco, CA
Increased Liver Cell Steatosis and Apoptosis Represent a Mechanism towards Increased Liver Injury in Experimental Liver Fibrosis
(1412)
C Kalogeropoulou, I Tsota, P Zabakis, V Tzelepi, T Petsas, D Kardamakis, A Tsamandas - University of Patras School of Medicine, Patras, Greece
The Role of Hepatic Steatosis in Acetaminophen Hepatotoxicity
(1432)
A Manuyakorn, N Logan, D Gjertson, JC Hong, S French - Siriraj Hospital, Bangkok, Thailand; UCLA, Los Angeles, CA
Temporal Evolution of Amoxicillin-Clavulanate Induced Liver Injury
(1430)
H Mani, R Saxena, JH Hoofnagle, DE Kleiner - NCI, NIH, Bethesda; Indiana University, Indianapolis, IN; NIDDK, NIH, Bethesda; For the Drug Induced Liver Injury Network
"Two Toned Hepatocytes": A Striking Histologic Change Likely Due to a Drug Effect
(1428)
Q Liu, KE Tanaka, KM Whitney, J Hart - Montefiore Hospital, New York; University of Chicago, Chicago, IL
Black Cohosh Induced Acute Hepatotoxicity Featuring Centrilobular Necrosis and Autoimmune Hepatitis
(1405)
G Guzman, C Wojweda, ER Kallwitz, SJ Cotler - University of Illinois, Chicago; Case Western Reserve University, Cleveland, OH
Histopathology of Idiopathic Portal Hypertension in Patients with HIV Infection Treated with HAART
(1436)
R Miquel, P Chang, JL Blanco, M Laguno, J Gonzalez-Abraldes, J Bosch, JC Garcia-Pagan, M Bruguera - Hospital Clinic, IDIBAPS, UB, Barcelona, Spain
Perinodular K19 Patterns Are Generic to Advanced Chronic Liver Disease, a Study of 176 Hepatocellular Nodules in Explanted Livers
(1422)
JKM Lennerz, N Vachharajani, WC Chapman, EM Brunt - Washington University St. Louis, St. Louis, MO
The Significance of On-Site Evaluation of Image-Guided Core Needle Biopsy of Liver Masses
(1474)
S Williams, S Sahoo, H Alatassi - University of Louisville, Louisville, KY
Useful Pathologic Features To Distinguish Telangiectatic/Inflammatory Hepatocellular Adenoma from Other Benign Hepatocellular Tumors
(1464)
AA Suriawinata, KH Lim, MI Fiel, L Qin, S Ward, DJ van Leeuwen, SN Thung - Dartmouth-Hitchcock Medical Center, Lebanon, NH; Singapore General Hospital, Singapore, Singapore; Mount Sinai Medical Center, New York, NY
IMP3 Expression Can Distinguish Hepatocellular Carcinoma from Hepatocellular Adenoma
(1472)
DG Wagner, Q Yang, LA McMahon, BO Spaulding, HL Wang, H Xu - University of Rochester Medical Center, Rochester; Dako North America, Carpinteria, Carpinteria; Cedars-Sinai Medical Center, Los Angeles, CA
Chromosomal Gains Demonstrated by Fluorescent In Situ Hybridization Are Helpful in the Diagnosis of Atypical Hepatocellular Neoplasms
(1411)
S Kakar, JP Grenert, E Pease, O Adeyi, LD Ferrell - UCSF, San Francisco; Univ of Toronto, Toronto, Canada
Hepatocellular Carcinoma with Progenitor Cell Features: High Expression of Invasion and Epithelial Mesenchymal Transition-Associated Genes
(1421)
J-E Lee, B-K Oh, J Choi, S-M Yoon, T-H Um, YN Park - Yonsei University College of Medicine, Seoul, Republic of Korea
FOXP3 Positive Tumor-Infiltrating Lymphocytes in Hepatocellular Carcinoma: A Clinicopathologic Study
(1414)
MJ Kapadia, J Alexander, LE Kernochan, MM Yeh - University of Washington, Seattle, WA
Prognostic Implications of and Relationship between CpG Island Hypermethylation and Repetitive DNA Hypomethylation in Hepatocellular Carcinoma
(1420)
HS Lee, BH Kim, NY Cho, SH Shin, JJ Jang, KS Suh, GH Kang - Seoul National University College of Medicine and Cancer Research Institute, Seoul, Republic of Korea
Expression of Matrix Metalloproteinase Type 9 in Hepatocellular Carcinoma and Correlation with Histopathologic Parameter
(1439)
D Nart, N Incili, M Zeytunlu, M Kilic, Z Karasu, F Yilmaz - Ege University Faculty of Medicine, Izmir, Turkey
Advantages and Pitfalls of Glypican-3 Immunohistochemistry in the Distinction of Hepatocellular Carcinoma and Metastatic Carcinomas
(1448)
R Ramachandran, LW Browne, S Kakar - UCSF, San Francisco, CA
Expression of Glypican-3 in Embryonal Sarcoma and Mesenchymal Hamartoma of the Liver: A Potential Diagnostic Pitfall
(1423)
M Levy, D Dhall, J Zhang, L Miles, J Misdraji, LM Yerian, H Xu, CE Aguilar, HL Wang - Cedars-Sinai Medical Center, Los Angeles; Mayo Clinic, Rochester; Cincinnati Children's Hospital, Cincinnati; MGH/Harvard Medical School, Boston; Cleveland Clinic, Cleveland; University of Rochester Medical Center, Rochester, NY
Expression of Hepatocyte and Cholangiocyte Transcription Factors in Hepatocellular Carcinoma, Cholangiocarcinoma, and Combined Hepatocellular and Cholangiocarcinoma: Implication for the Process of Transdifferentiation
(1454)
E Sasatomi, E Ochoa, K Isse, MA Nalesnik, T Wu, AJ Demetris - University of Pittsburgh Medical Center, Pittsburgh, PA
The Role of RCC-MA in Evaluating Primary and Metastatic Clear Cell Carcinomas in the Liver
(1469)
DL Tunnell, MP Bronner - Cleveland Clinic, Cleveland, OH
Hepatocellular Carcinoma, Renal Cell Carcinoma Metastatic to Liver, and Adrenal Carcinoma Metastatic to Liver: Immunostaining for Bile Salt Export Pump as a Marker of Hepatocellular Differentiation
(1415)
AS Knisely - King's College Hospital, London, United Kingdom
Neoadjuvant Chemotherapy Followed by Two-Step Hepatectomy for Bilateral Hepatic Colorectal Liver Metastases. Clinical and Histological Outcomes with a Focus on the "Dangerous Halo"
(1433)
G Mentha, S Terraz, P Morel, A Andres, E Giostra, A Roth, L Rubbia-Brandt, P Majno - University Hospitals of Geneva, Geneva, Switzerland
Patterns of Histological Alteration and Their Clinical Significance in Colorectal Liver Metastases Following Preoperative Chemotherapy
(1391)
F Bao, J Park, D Klimstra, P Mastrodomenico, N Katabi, E Vakiani, L Tang, M D'Angelica, J Shia - Memorial Sloan-Kettering Cancer Center, NY
Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia Are Major Hepatic Lesions Associated with Oxaliplatin Based Chemotherapy for Colorectal Liver Metastases and Partially Prevented by Bevacizumab
(1452)
L Rubbia-Brandt, GY Lauwers, H Wang, PE Majno, K Tanabe, A Zhu, C Brezault, O Soubrane, EK Abdalla, J-N Vauthey, G Mentha, B Terris - University Hospital, Geneva, Switzerland; Massachusetts General Hospital, Boston, MA; M.D. Anderson Cancer Center, University of Texas, Houston, TX; University Hospital, Geneva, Switzerland; Hopital Cochin, Paris, France; Hopital Cochin, Paris, France
The Role of Post-Reperfusion Biopsy in the Era of Extended Criteria Donor: Clinicopathologic Correlation and Follow-Up Analysis of 50 Liver Transplant Patients, a Prospective Study
(1449)
M Raoufi, C Ma, A Ormsby, H Vakil, K Brown, MA Huang, D Moonka, M Abouljoud - Henry Ford Hospital, Detroit, MI; Wayne State University, Detroit, MI
Periportal Apoptotic Bodies Are Helpful in Distinguishing Recurrent Hepatitis C from Rejection in Liver Allograft Biopsies
(1470)
WS Twaddell, JH Lefkowitch - University of Maryland Medical Center, Baltimore, MD; Columbia University Medical Center, New York, NY
Risk Factors and Histologic Pathways of Fibrosis Progression and Architectural Distortion in Chronic Hepatitis C Virus Infection after Liver Transplantation
(1442)
EO Ochoa, G Alarcon, Z Gao, DT Tran, AJ Demetris - University of Pittsburgh Medical Center, Pittsburgh, PA; Hospital Universitario de la UANL, Monterrey, Nuevo Leon, Mexico; University of Calgary, Calgary, AB, Canada
button next to any title to add to Itinerary Planner...
Add
